- Bank OZK shares fell more than 5% after Citi analysts said a roughly six-week extension on IQHQ’s $915M San Diego construction loan looked like a stopgap to avoid default.
- The amended loan now comes due Oct. 9, 2026, and Bank OZK told Bisnow short extensions are routine while longer ones are documented, with an update promised on its Oct. 21 earnings call.
- IQHQ’s $1.6B life sciences campus of 1.7M SF finished in 2024 with no tenants in place, and six funds holding $707M in IQHQ positions marked them down in late 2025.
Shares of Bank OZK dropped more than 5% this week after Citi analysts questioned a short extension tied to a $915M construction loan to IQHQ in San Diego, according to Bisnow.
Citi’s research note read the roughly six-week extension as a stopgap rather than a solution.
Get Smarter about what matters in CRE
Stay ahead of trends in commercial real estate with CRE Daily – the free newsletter delivering everything you need to start your day in just 5-minutes
What Citi Saw
Maturity now falls on Oct. 9, 2026. OZK signed the amendment Sept. 30 and IQHQ signed Oct. 1, yet it carries an effective date of Aug. 26, after the original maturity had already passed.
Citi analysts took that timing as a last-minute effort to head off a default. They wrote that the result suggests the two sides could not agree on a longer extension or a refinancing, though the window buys time to work out a deeper restructuring. In their view it also signals serious financial distress at the project.
The Bank’s Response
In an email to Bisnow on Wednesday, Bank OZK communications chief Michelle Rossow said brief extensions are routine in complicated deals while the parties finish documents for longer ones.
On the July second-quarter call, President Brannon Hamblen said the bank was negotiating with IQHQ and its mezzanine lender over a recapitalization and an extension spanning several years, with terms not yet fully developed. He expected to have more to share when third-quarter results are discussed Oct. 21, after the amended maturity.
A Struggling Life Sciences Project
RaDD, the $1.6B Research and Development District, broke ground in 2021 and was finished in 2024 with zero tenants committed. IQHQ has found the 1.7M SF campus hard to fill.
The bet has weighed on IQHQ’s investors. Six registered funds with a combined $707M allocated to the company marked down their positions during the back half of 2025.
Why It Matters
Investors are watching how a regional bank handles a large construction loan on a vacant life sciences project. The drop in OZK’s shares shows how quickly a single exposure can move sentiment.
The bank has been recalibrating its lending, as CRE Daily reported when Bank OZK capped loan sizes ahead of more rate cuts.
What’s Next
The amended maturity arrives Oct. 9 and the earnings call follows on Oct. 21. Watch for news of a longer extension, a recapitalization with the mezzanine lender, or a default.
